Journal of International Oncology ›› 2020, Vol. 47 ›› Issue (8): 492-495.doi: 10.3760/cma.j.cn371439-20191112-00063
• Reviews • Previous Articles Next Articles
Liu Junguo, Zhang Jinjuan, Wang Yijun()
Received:
2019-11-12
Revised:
2020-02-20
Online:
2020-08-08
Published:
2020-10-22
Contact:
Wang Yijun
E-mail:wangyijun_carl@163.com
Supported by:
Liu Junguo, Zhang Jinjuan, Wang Yijun. Clinical application progress of variations in the technique of liver partition from ALPPS[J]. Journal of International Oncology, 2020, 47(8): 492-495.
[1] |
Tong YF, Meng N, Chen MQ, et al. Maturity of associating liver partition and portal vein ligation for staged hepatectomy-derived liver regeneration in a rat model[J]. World J Gastroenterol, 2018,24(10):1107-1119. DOI: 10.3748/wjg.v24.i10.1107.
doi: 10.3748/wjg.v24.i10.1107 pmid: 29563755 |
[2] |
Treska V. Methods to increase future liver remnant volume in patients with primarily unresectable colorectal liver metastases: current state and future perspectives[J]. Anticancer Res, 2016,36(5):2065-2071.
pmid: 27127106 |
[3] |
Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma[J]. Hepatology, 2002,35(3):519-524. DOI: 10.1053/jhep.2002.32089.
doi: 10.1053/jhep.2002.32089 pmid: 11870363 |
[4] |
Schadde E, Ardiles V, Robles-Campos R, et al. Early survival and safety of ALPPS: first report of the international ALPPS registry[J]. Ann Surg, 2014,260(5):829-838. DOI: 10.1097/SLA.0000000000000947.
doi: 10.1097/SLA.0000000000000947 pmid: 25379854 |
[5] |
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings[J]. Ann Surg, 2012,255(3):405-414. DOI: 10.1097/SLA.0b013e31824856f5.
doi: 10.1097/SLA.0b013e31824856f5 pmid: 22330038 |
[6] |
de Santibanes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach[J]. Ann Surg, 2012,255(3):415-417. DOI: 10.1097/SLA.0b013e318248577d.
doi: 10.1097/SLA.0b013e318248577d pmid: 22330039 |
[7] |
Aloia TA, Vauthey JN. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost?[J]. Ann Surg, 2012,256(3):e9-e19. DOI: 10.1097/SLA.0b013e318265fd3e.
doi: 10.1097/SLA.0b013e318265fd3e pmid: 22868369 |
[8] |
Rohatgi S, Harrison EM, Powell JJ, et al. ALPPS: adverse outcomes demand clear justifification in an era of improving survival for colorectal liver metastases[J]. World J Surg, 2015,39(7):1848-1849. DOI: 10.1007/s00268-014-2726-5.
doi: 10.1007/s00268-014-2726-5 pmid: 25145819 |
[9] |
Vauthey JN, Mise Y. Commentary on "can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases?"[J]. Surgery, 2015,157(2):207-210. DOI: 10.1016/j.surg.2014.08.093.
doi: 10.1016/j.surg.2014.08.093 pmid: 25433731 |
[10] |
Schlegel A, Lesurtel M, Melloul E, et al. ALPPS: from human to mice highlighting accelerated and novel mechanisms of liver regeneration[J]. Ann Surg, 2014,260(5):839-847. DOI: 10.1097/SLA.0000000000000949.
doi: 10.1097/SLA.0000000000000949 pmid: 25379855 |
[11] |
Alvarez FA, Ardiles V, de Santibanes M, et al. Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center[J]. Ann Surg, 2015,261(4):723-732. DOI: 10.1097/SLA.0000000000001046.
doi: 10.1097/SLA.0000000000001046 pmid: 25493362 |
[12] |
Petrowsky H, Györi G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? A single-center experience[J]. Ann Surg, 2015,261(4):e90-e92. DOI: 10.1097/SLA.0000000000001087.
doi: 10.1097/SLA.0000000000001087 pmid: 25706390 |
[13] |
Tanaka K, Kikuchi Y, Kawaguchi D, et al. Modified ALPPS procedures avoiding division of portal pedicles[J]. Ann Surg, 2017,265(2):e14-e20. DOI: 10.1097/SLA.0000000000001967.
pmid: 27611614 |
[14] |
Gall TM, Sodergren MH, Frampton AE, et al. Radio-frequency-assisted liver partition with portal vein ligation (RALPP) for liver regeneration[J]. Ann Surg, 2015,261(2):e45-e46. DOI: 10.1097/SLA.0000000000000607.
doi: 10.1097/SLA.0000000000000607 pmid: 24670841 |
[15] |
Jiao LR, Fajardo Puerta AB, Gall TMH, et al. Rapid induction of liver regeneration for major hepatectomy (REBIRTH): a randomized controlled trial of portal vein embolisation versus ALPPS assisted with radiofrequency[J]. Cancers (Basel), 2019,11(3):302. DOI: 10.3390/cancers11030302.
doi: 10.3390/cancers11030302 |
[16] |
Tang K, Zhang B, Dong L, et al. Successful treatment of a huge hepatic carcinoma with right portal vein rhrombosis: a case report[J]. Medicine (Baltimore), 2020,99(17):e19636. DOI: 10.1097/MD.0000000000019636.
doi: 10.1097/MD.0000000000019636 |
[17] |
Gringeri E, Boetto R, D'Amico FE, et al. Laparoscopic microwave ablation and portal vein ligation for staged hepatectomy (LAPS): a minimally invasive fifirst-step approach[J]. Ann Surg, 2015,261(2):e42-e43. DOI: 10.1097/SLA.0000000000000606.
doi: 10.1097/SLA.0000000000000606 pmid: 24651131 |
[18] |
Cillo U, Gringeri E, Feltracco P, et al. Totally laparoscopic microwave ablation and portal vein ligation for staged hepatectomy: a new minimally invasive two-stage hepatectomy[J]. Ann Surg Oncol, 2015,22(8):2787-2788. DOI: 10.1245/s10434-014-4353-7.
pmid: 25605516 |
[19] |
Robles R, Parrilla P, López-Conesa A, et al. Tourniquet modifification of the associating liver partition and portal ligation for staged hepatectomy procedure[J]. Br J Surg, 2014,101(9):1129-1134. DOI: 10.1002/bjs.9547.
doi: 10.1002/bjs.9547 pmid: 24947768 |
[20] |
Robles Campos R, Parrilla Paricio P, López Conesa A, et al. A new surgical technique for extended right hepatectomy: tourniquet in the umbilical fissure and right portal vein occlusion (ALTPS). Clinical case[J]. Cir Esp, 2013,91(10):633-637. DOI: 10.1016/j.ciresp.2013.09.004.
pmid: 24246509 |
[21] |
Li J, Ewald F, Gulati A, et al. Associating liver partition and portal vein ligation for staged hepatectomy: From technical evolution to oncological benefifit[J]. World J Gastrointest Surg, 2016,8(2):124-133. DOI: 10.4240/wjgs.v8.i2.124.
pmid: 26981186 |
[22] |
Cai X, Peng S, Duan L, et al. Completely laparoscopic ALPPS using round-the-liver ligation to replace parenchymal transection for a patient with multiple right liver cancers complicated with liver cirrhosis[J]. J Laparoendosc Adv Surg Tech A, 2014,24(12):883-886. DOI: 10.1089/lap.2014.0455.
pmid: 25387325 |
[23] |
Robles Campos R, Brusadin R, López Conesa A, et al. Staged liver resection for perihilar liver tumors using a tourniquet in the umbilical fifissure and sequential portal vein embolization on the fourth post-operative day (a modifified ALTPS)[J]. Cir Esp, 2014,92(10):682-686. DOI: 10.1016/j.ciresp.2014.07.006.
doi: 10.1016/j.ciresp.2014.07.006 pmid: 25151854 |
[24] |
Li J, Kantas A, Ittrich H, et al. Avoid "all-touch" by hybrid ALPPS to achieve oncological effificacy[J]. Ann Surg, 2016,263(1):e6-e7. DOI: 10.1097/SLA.0000000000000845.
pmid: 25072445 |
[25] |
Cai YL, Song PP, Tang W, et al. An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence[J]. Medicine (Baltimore), 2016,95(24):e3941. DOI: 10.1097/MD.000000000-0003941.
doi: 10.1097/MD.0000000000003941 |
[26] |
Lai Q, Melandro F, Rossi M. Hybrid partial ALPPS: a feasible approach in case of right trisegmentectomy and macrovascular invasion[J]. Ann Surg, 2018,267(4):e80-e82. DOI: 10.1097/SLA.0000000000002219.
doi: 10.1097/SLA.0000000000002158 pmid: 28134684 |
[27] |
Peng SY, Wang XA, Huang CY, et al. Evolution of associating liver partition and portal vein ligation for staged hepatectomy: simpler, safer and equally effective methods[J]. World J Gastroenterol, 2017,23(23):4140-4145. DOI: 10.3748/wjg.v23.i23.4140.
doi: 10.3748/wjg.v23.i23.4140 pmid: 28694654 |
[28] |
Xiao N, Yu K, Yu S, et al. The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresec-table colorectal liver metastasis: a case report and literature review[J]. World J Surg Oncol, 2017,15(1):148. DOI: 10.1186/s12957-017-1212-6.
pmid: 28774330 |
[29] | 彭淑牖, 黄从云, 李江涛, 等. 末梢门静脉栓塞术在计划性肝切除术中的应用初探[J]. 中华外科杂志, 2016,54(9):664-668. DOI: 10.3760/cma.j.issn.0529-5815.2016.09.004. |
[1] | Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[2] | Peng Qin, Cai Yuting, Wang Wei. Advances on KPNA2 in liver cancer [J]. Journal of International Oncology, 2024, 51(3): 181-185. |
[3] | Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis [J]. Journal of International Oncology, 2024, 51(2): 114-118. |
[4] | Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong. Effects of Anhydroicaritin on the proliferation, migration and apoptosis of hepatocellular carcinoma cells [J]. Journal of International Oncology, 2023, 50(9): 513-519. |
[5] | Li Jiaxuan, Feng Yinglu. Mechanism of action of glucocorticoid receptors in the growth of hepatoma cells [J]. Journal of International Oncology, 2023, 50(4): 241-243. |
[6] | He Ting, Wang Xi, Zhang Huizhong, Liu Xinyang, Wang Huiping, Dong Ke. Diagnostic value of serum TIM-3 in patients with liver cancer [J]. Journal of International Oncology, 2022, 49(9): 537-542. |
[7] | Zhang Yumin, Zhao Xianwei, He Qianjin, Chen Jieneng. Value of contrast-enhanced ultrasound combined with serum CXCL8 and CXCR2 in the evaluation of postoperative efficacy of transcatheter arterial chemoembolization for primary liver cancer [J]. Journal of International Oncology, 2022, 49(10): 592-596. |
[8] | Di Weihua, Zhao Xuemei. Research progress on the relationship between DNA damage repair genes and liver cancer [J]. Journal of International Oncology, 2022, 49(10): 635-638. |
[9] | Du Jiahang, Chen Dong, Chen Yaoting. Research progress of arsenic trioxide in anti-liver cancer mechanism and treatment of hepatocellular carcinoma [J]. Journal of International Oncology, 2021, 48(9): 572-. |
[10] | Han Baojun. Expression of histone acetyltransferase P300 in hepatocellular carcinoma tissue and its clinical significance [J]. Journal of International Oncology, 2021, 48(7): 415-419. |
[11] | Zhang Yuyuan, Li Zhen, Zhan Pengchao, Li Xin, Ye Shuwen, Wang Caihong, Liu Yang. Progress of biomarkers in liver cancer [J]. Journal of International Oncology, 2021, 48(4): 241-245. |
[12] | Xiong Lin, Zhang Xiuyun, Zhang Xiaoyu, Li Yue, Xu Ximing. IWR-1-endo affects the migration and proliferation of hepatocarcinoma cells by inhibiting the Wnt pathway [J]. Journal of International Oncology, 2021, 48(12): 711-715. |
[13] | Xin Ruiqiang, Song Xiaoping, Zhang Fan, Sun Ying, Wang Tao, Sun Wei. Mechanism of SUMO regulating XBP1 mediated endoplasmic reticulum stress on the progression of liver cancer [J]. Journal of International Oncology, 2020, 47(7): 397-403. |
[14] | Zhao Chuanxi, Zhu Tingting, Liu Mingguo, Cao Lili. Advances of Krüppel-like factors in hepatocellular carcinoma [J]. Journal of International Oncology, 2020, 47(2): 119-122. |
[15] | Song Quan, Ding Ningling, Xu Ying, Cao Kaiyue, Zhou Sufang, Zhao Aiqin, Pan Yunzhi, Ma Sai. Exosomal miR-196a derived from liver cancer stem cell enhances liver cancer cells resistance to doxorubicin [J]. Journal of International Oncology, 2020, 47(10): 585-592. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||